返回 Agendas
Session Chair(s)
Anthony Ridgway, PHD
Acting Director, Biologics and Genetic Therapies Directorate
Health Canada, Canada
Speaker(s)
An Industrial View of Comparability Applied to Biopharmaceuticals
Anthony S Lubiniecki
Janssen R&D LLC, United States
Senior Scientific Director & Fellow
FDA Perspective
Linan Ha
FDA, United States
Team Leader, Division of Biotechnology Review & Research I, OBP, OPQ, CDER
European Perspective
Kowid Ho, PHARMD
F. Hoffmann-La Roche Ltd, Switzerland
Pharma Technical Regulatory Policy